SarcRisk

AnnieGuard detects sarcoma before it’s obvious — even when it hides in plain sight.

Our SarcRisk™ engine runs quietly in your EHR, continuously analyzing clinical, anatomical, and molecular data to flag soft tissue sarcomas that appear early-stage but are biologically advanced.

Built to close the 16% early detection gap, SarcRisk identifies threat patterns invisible to traditional tools — enabling smarter intervention, earlier treatment, and better outcomes.

This isn’t just early detection.
It’s anti-spoofing for cancer.